CKB News Archive

• 2018
• November
  • Vitrakvi (larotrectinib) approved regardless of tumor type for NTRK fusions, except with acquired resistance mutations! Need a list of resistance mutations? Visit ckbhome.jax.org and sign-up for CKB BOOST.

• 2018
• September
  • Check out the Bio-IT World commentary on JAX-CKB!

• 2018
• July
  • JAX-CKB now includes transcript information for gene variants.

• 2018
• May
  • Interested in learning more about JAX-CKB? Check out this video!
  • Thank you, Bio-IT World! JAX-CKB receives an honorable mention for the 2018 Best Practices Awards!

• 2017
• October
  • Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinic (PMID: 28402162). Limited free copies available; request your copy at ckbsupport@jax.org.